Evonik facing a supply shortage for ThreAMINO

evonik afFollowing the escalation of COVID-19 outbreak, Evonik’s contract manufacturer had shut-down its production facilities, as production and shipping of the amino acid ThreAMINO are affected

Dr Emmanuel Auer, head of animal nutrition business line at Evonik, explained, “We are facing a supply shortage for ThreAMINO. We have, therefore, decided to send a Force Majeure notification to our customers with immediate effect, in accordance with our contracts.”

“Meanwhile, we try the utmost to mitigate this situation and re-establish supply to our customers as fast as possible.”

Evonik is keeping its customers regularly informed as the situation develops.

Alain Charles Publishing, University House, 11-13 Lower Grosvenor Place, London, SW1W 0EX, UK
T: +44 20 7834 7676, F: +44 20 7973 0076, W: www.alaincharles.com

twn Are you sure that you want to switch to desktop version?